Multi -discipline helps esophageal cancer precision diagnosis and treatment.

Esophageal cancer is one of the common malignant tumors in the world, and the incidence has risen in recent years. Research data show that the incidence and mortality rate of esophageal cancer in my country are much higher than global and early detection rates are low. The postoperative recurrence or metastasis rate is high. The effect of poor prognosis has limited efficacy and large side effects. The incidence of esophageal cancer in Guangdong is significantly higher than that of other provinces. How to accurately and effectively treat esophageal cancer has become more urgent.

To this end, the Guangdong Provincial Society of Precision Medicine is vigorously promoting the construction of esophageal cancer branches featuring multi -disciplinary integration. On July 21, 2022, under the convening and organization of Professor Qiao Guibin, led by the branch led by the branch, the first preparation meeting of the esophageal cancer branch was successfully held in Guangzhou. Experts from many fields such as thoracic surgery, oncology, radiotherapy, and digestive departments have gathered together to discuss the promotion matters for the joint branches to build a force for the health of the people.

Preparatory meeting site

Professor Joe

Guangdong Provincial Precision Medicine Application Society, esophageal cancer branch led by the sponsor

Chief Physician of Cheung Surgery Department of Guangdong Provincial People's Hospital

Experts participating in this preparatory meeting include:

Chief Physician at the Department of Chestning of the People's Hospital of Guangdong Provincial People's Hospital

Chief Physician of the Department of Radio Department of Southern Hospital of Wu Dehua Southern Medical University

Chief Physician of the Department of Oncology, Zhao Jianfu, First Affiliated Hospital of Jinan University

Xie Songxi Deputy Chief Physician of the Department of Radio and therapy of Guangdong Provincial People's Hospital

Li Zhuoyi's deputy chief physician of thoracic surgery at the First Affiliated Hospital of Guangzhou Medical University

Deputy Chief Physician of the Department of Gastroenterology, Southern Hospital of Baiyang Southern Medical University

Liu Jianhua, deputy chief physician of the Department of Internal Medicine of the People's Hospital of Guangdong Province

Tang Jiming Deputy Chief Physician at the Department of Chestning of Guangdong Provincial People's Hospital

Professor Joe VIP said that in recent years, the diagnosis and treatment of esophageal cancer have gradually tended to individualization and precision. When applying multi -mode treatment, including chemotherapy, targeted therapy, and immunotherapy, the overall efficiency and survival rate of patients have been greatly improved. At the same time, through multidisciplinary biotechnology such as molecular biology, protein group, and genomics, it can further explore the occurrence and progress mechanism of esophageal cancer from various levels such as tissue, cells, protein, and molecular levels, and then promote the improvement of esophageal cancer prevention and treatment level. Essence

According to Professor Qiao Guibin, precision medicine treatment of esophageal cancer is in line with the general trend of international academic development, and it is an effective measure to advance with the times. During the preparation process, the branch will widely absorb the head expert resources in the field of Guangdong Province, domestic and international esophageal cancer, unity basic research, transformation applications, and medical and health, life, biomedicine, big data, artificial intelligence, health industry, etc. Professional forces in the field, leading, promoting, standardizing the research and application of new products, new methods, and new products in esophageal cancer diseases, further implement the country's important instructions for medical health development, and complete the strategic goals of Guangdong Province's health provincial province Specific requirements, continuously promote the research and application of precision medical research and application of esophageal cancer to the new level and reach a new level.

Sun Binggang, Executive Vice President and Secretary -General of the Society, Zhang Lu, deputy secretary -general Zhang Lu, and relevant comrades of the Academic Department attended the meeting. Sun Binggang said that under the leadership of Professor Qiao Guibin, under the joint efforts of experts such as various disciplines, the branch will continue to explore on the road to the treatment of esophageal cancer diseases in a more accurate system, to contribute to the construction of healthy Guangdong and healthy China. Academic exchanges, research reports, joint research, standard preparation, technical training, technical promotion, and popular science propaganda work have achieved good results.

- END -